journal Journal For International Medical Graduates Journal For International Medical Graduates California Institute of Behavioral Neurosciences and Psychology US https://www.cibnp.com 2832-9864 155 Articles Therapeutics Uses of Psychedelics in Patients With Psychiatric Disorders a Systematic Review Sarosh Nawaz, MBBS Nawaz Sarosh sarosh.nawaz@hotmail.com Abdulaziz Mohammed Althwanay Althwanay Abdulaziz Mohammed abdulaziz.mohammed.althwanay@jimgs.com Esraa M. AlEdani, MB Ch B AlEdani Esraa M. esraaaledani0gmail.com Harleen Kaur Kaur Harleen harleen.kaur@jimgs.com Malik Kasapoglu Kasapoglu Malik malik.kasapoglu@jimgs.com Rajesh Yadavalli MBBS Yadavalli Rajesh rajesh.yadavalli@jimgs.com Ann Kashmer Yu Yu Ann Kashmer ann.kashmer.yu@jimgs.com Department of Psychiatry, California Institute of Behavioural Neurosciences and Psychology, Fairfield, USA Imam Abdulrahman Bin Faisal University Department of Internal medicine, California Institute of Behavioural Neurosciences and Psychology, Fairfield, USA California Institute of Behavioural Neurosciences and Psychology, Fairfield, USA 18 04 2024 Received: 1842024 Copyright (c) 2024 Journal For International Medical Graduates 2024 Journal For International Medical Graduates Psychedelic/ Psychotropic drugs/ Hallucinogen Serotonin receptors LSD mescaline ayahuasca Therapeutic uses Psychiatric Diseases/Mental health Psychotherapy Alcohol and Drug Foundation. Psychedelics - Alcohol and Drug Foundation [Internet]. Adf.org.au. 2021. Available from: https://adf.org.au/drug-facts/psychedelics/ Alcohol and Drug Foundation. Psychedelics - Alcohol and Drug Foundation [Internet]. Adf.org.au. 2021. Belouin SJ, Henningfield JE. Psychedelics: Where we are now, why we got here, what we must do. Neuropharmacology [Internet]. 2018 Nov;142:7–19. Available from: https://pubmed.ncbi.nlm.nih.gov/29476779/ Wikipedia Contributors. History of lysergic acid diethylamide [Internet]. Wikipedia. Wikimedia Foundation; 2019. Available from: https://en.wikipedia.org/wiki/History_of_lysergic_acid_diethylamide Tanne, Jannice. Humphry Osmond. BMJ [Internet]. 2004 Mar 18 [cited 2021 Feb 28];328(7441):713. Available from: https://doi.org/10.1136/bmj.328.7441.713 Hammel RL, Gulliver BJ, Sukich SN, Abraham SP. The Role of Psychedelics in Managing Anxiety, Depression, and Flashbacks of Individuals with Post-Traumatic Stress Disorder. International Journal of Science and Research Methodology [Internet]. 2022 Jan 31 [cited 2022 Mar 28];20(3):143–61. Available from: https://ijsrm.humanjournals.com/wp-content/uploads/2022/02/10.Reace-L.-Hammel-Berry-J.-Gulliver-Shelby-N.-Sukich-Samuel-P.-Abraham.pdf Ross S, Agrawal M, Griffiths RR, Grob C, Berger A, Henningfield JE. Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care. Neuropharmacology [Internet]. 2022 Sep;216:109174. Available from: https://doi.org/10.1016/j.neuropharm.2022.10917 Nichols DE. Psychedelics. Pharmacological Reviews [Internet]. 2016 Feb 3;68(2):264–355. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813425/ Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology [Internet]. 2009 Oct;62(10):e1–34. Available from: https://www.sciencedirect.com/science/article/pii/S08 95435609001802 PRISMA. PRISMA flow diagram [Internet]. www.prisma-statement.org. 2020. Available from: http://www.prisma-statement.org/PRISMAStatement/FlowDiagram Baethge C, Goldbeck-Wood S, Mertens S. SANRA—a scale for the quality assessment of narrative review articles. Research Integrity and Peer Review [Internet]. 2019 Mar 26;4(1). Available from: https://researchintegrityjournal.biomedcentral.com/art icles/10.1186/s41073-019-0064-8 Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ [Internet]. 2017 Sep 21;358(8122):j4008. Available from: https://www.bmj.com/content/358/bmj.j4008 Crane M. Drug Classifications: Scheduling of Narcotics and Prescription Drugs [Internet]. American Addiction Centers. 2018. Available from: https://americanaddictioncenters.org/prescription-drugs/classifications Vollenweider FX, Preller KH. Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. Nature Reviews Neuroscience [Internet]. 2020 Sep 14;21(11):611–24. Available from: https://www.nature.com/articles/s41583-020-0367-2 Nutt D, Spriggs M, Erritzoe D. Psychedelics therapeutics: What we know, what we think, and what we need to research. Neuropharmacology [Internet]. 2022 Sep [cited 2022 Oct 1];109257. Available from: https://doi.org/10.1016/j.neuropharm.2022.109257 Kent J. Neurotransmitters & Neuromodulators: The Psychedelic Connection : James Kent [Internet]. www.tripzine.com. Available from: http://www.tripzine.com/listing.php?smlid=362 Aqil M, Roseman L. More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics. Neuropharmacology [Internet]. 2023 Feb [cited 2022 Nov 26];223:109300. Available from: https://doi.org/10.1016/j.neuropharm.2022.109300 Rucker JJH, Iliff J, Nutt DJ. Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology [Internet]. 2018 Nov;142:200–18. Available from: https://www.sciencedirect.com/science/article/pii/S00 2839081730638X Javidi H, Yadollahie M. Post-traumatic Stress Disorder. The International Journal of Occupational and Environmental Medicine [Internet]. 2012 Jan 1;3(1):2–9. Available from: https://pubmed.ncbi.nlm.nih.gov/23022845/ Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology [Internet]. 2016 Nov 30;30(12):1181–97. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367557/ Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, et al. Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer. Archives of General Psychiatry [Internet]. 2011 Jan 3;68(1):71. Available from: https://doi.org/10.1001/archgenpsychiatry.2010.116 Ameli R, Sinaii N, Luna MJ, Cheringal J, Gril B, Berger A. The National Institutes of Health measure of Healing Experience of All Life Stressors (NIH-HEALS): Factor analysis and validation. ten Klooster PM, editor. PLOS ONE [Internet]. 2018 Dec 12;13(12):e0207820. Available from: https://doi.org/10.1371/journal.pone.0207820 Ross S. Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress. International Review of Psychiatry. 2018 Jul 4;30(4):317–30. Ayahuasca [Internet]. Multidisciplinary Association for Psychedelic Studies - MAPS. Available from: https://maps.org/ayahuasca/ Chao YS, Horton J. Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders [Internet]. PubMed. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021. Available from: https://pubmed.ncbi.nlm.nih.gov/36170470/ Nichols DE, Walter H. The History of Psychedelics in Psychiatry. Pharmacopsychiatry [Internet]. 2020 Dec 7;54(4). Available from: https://doi.org/10.1055/a-1310-3990 Turton S, Nutt DJ, Carhart-Harris RL. A Qualitative Report on the Subjective Experience of Intravenous Psilocybin Administered in an fMRI Environment. Current Drug Abuse Reviews [Internet]. 2015 Jan 27 [cited 2019 Oct 29];7(2):117–27. Available from: https://doi.org/10.2174/1874473708666150107120930 Schmid Y, Enzler F, Gasser P, Grouzmann E, Preller KH, Vollenweider FX, et al. Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects. Biological Psychiatry [Internet]. 2015 Oct;78(8):544–53. Available from: https://doi.org/10.1016/j.biopsych.2014.11.015 Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin. Human Brain Mapping. 2015 May 22;36(8):3137–53. doi: 10.1002/hbm.22833 Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, et al. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychological Medicine. 2018 Jun 15;49(4):655–63. doi:10.1017/S0033291718001356 Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, et al. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Scientific Reports [Internet]. 2017 Oct 13;7(1). DOI: 10.1038/s41598-017-13282-7 Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics. 2019 May;197:83–102. DOI: 10.1016/j.pharmthera.2018.11.010 Carhart-Harris RL, Bolstridge M, Rucker J, Day CMJ, Erritzoe D, Kaelen M, et al. Psilocybin with Psychological Support for treatment-resistant depression: an open-label Feasibility Study. The Lancet Psychiatry [Internet]. 2016 Jul;3(7):619–27. DOI: 10.1016/S2215-0366(16)30065-7 Carhart-Harris RL, Friston KJ. REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. Barker EL, editor. Pharmacological Reviews. 2019 Jun 20;71(3):316–44. doi: 10.1124/pr.118.017160